Finance
GSK’s Older Respiratory Drugs Disappoint Amid Overhaul
GSK Plc’s older respiratory medicines showed lackluster sales in the first quarter, leaving HIV and cancer drugs to drive profit growth.
B
Bloomberg
April 29, 2026·1 min read
Image: Bloomberg
GSK Plc’s older respiratory medicines showed lackluster sales in the first quarter, leaving HIV and cancer drugs to drive profit growth.
Original article
GSK’s Older Respiratory Drugs Disappoint Amid Overhaul
Published by Bloomberg